| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = -$90 ) |
| | 2024 | 2021 | STATEGICS, INC. | 8 BAYCREST WAY | SOUTH SAN FRANCISCO | CA | 94080-7320 | SAN MATEO | USA | R44TR001596 | Homogeneous Screening Assay for Cytokine Receptor Modulators | 000 | 4 | NIH | 12/18/2023 | -$77 |
| | 2024 | 2021 | STATEGICS, INC. | 8 BAYCREST WAY | SOUTH SAN FRANCISCO | CA | 94080-7320 | SAN MATEO | USA | R44TR001596 | Homogeneous Screening Assay for Cytokine Receptor Modulators | 001 | 4 | NIH | 12/18/2023 | -$13 |
|
| Issue Date FY: 2022 ( Subtotal = -$1,173 ) |
| | 2022 | 2021 | STATEGICS, INC. | 8 BAYCREST WAY | SOUTH SAN FRANCISCO | CA | 94080-7320 | SAN MATEO | USA | R44TR001596 | Homogeneous Screening Assay for Cytokine Receptor Modulators | 000 | 4 | NIH | 4/15/2022 | $0 |
| | 2022 | 2017 | STATEGICS, INC. | 8 BAYCREST WAY | SOUTH SAN FRANCISCO | CA | 94080-7320 | SAN MATEO | USA | R43TR001596 | Development of a Homogeneous Screening Assay for the Tissue-Protective EPOR | 000 | 1 | NIH | 2/16/2022 | -$1,173 |
|
| Issue Date FY: 2021 ( Subtotal = $603,047 ) |
| | 2021 | 2021 | STATEGICS, INC. | 8 BAYCREST WAY | SOUTH SAN FRANCISCO | CA | 94080-7320 | SAN MATEO | USA | R44TR001596 | Homogeneous Screening Assay for Cytokine Receptor Modulators | 000 | 4 | NIH | 2/26/2021 | $515,113 |
| | 2021 | 2021 | STATEGICS, INC. | 8 BAYCREST WAY | SOUTH SAN FRANCISCO | CA | 94080-7320 | SAN MATEO | USA | R44TR001596 | Homogeneous Screening Assay for Cytokine Receptor Modulators | 001 | 4 | NIH | 3/15/2021 | $86,761 |
| | 2021 | 2017 | STATEGICS, INC. | 8 BAYCREST WAY | SOUTH SAN FRANCISCO | CA | 94080-7320 | SAN MATEO | USA | R43TR001596 | Development of a Homogeneous Screening Assay for the Tissue-Protective EPOR | 002 | 1 | NIH | 4/5/2021 | -$1,173 |
| | 2021 | 2017 | STATEGICS, INC. | 8 BAYCREST WAY | SOUTH SAN FRANCISCO | CA | 94080-7320 | SAN MATEO | USA | R43TR001596 | Development of a Homogeneous Screening Assay for the Tissue-Protective EPOR | 001 | 1 | NIH | 4/2/2021 | $1,173 |
| | 2021 | 2017 | STATEGICS, INC. | 8 BAYCREST WAY | SOUTH SAN FRANCISCO | CA | 94080-7320 | SAN MATEO | USA | R43TR001596 | Development of a Homogeneous Screening Assay for the Tissue-Protective EPOR | 000 | 1 | NIH | 4/2/2021 | $1,173 |
|
| Issue Date FY: 2020 ( Subtotal = $738,401 ) |
| | 2020 | 2020 | STATEGICS, INC. | 8 BAYCREST WAY | SOUTH SAN FRANCISCO | CA | 94080-7320 | SAN MATEO | USA | R44TR001596 | Homogeneous Screening Assay for Cytokine Receptor Modulators | 000 | 3 | NIH | 2/14/2020 | $738,401 |
|
| Issue Date FY: 2019 ( Subtotal = $722,532 ) |
| | 2019 | 2019 | STATEGICS, INC. | 8 BAYCREST WAY | SOUTH SAN FRANCISCO | CA | 94080-7320 | SAN MATEO | USA | R44TR001596 | Homogeneous Screening Assay for Cytokine Receptor Modulators | 000 | 2 | NIH | 3/1/2019 | $722,532 |
|
| Issue Date FY: 2018 ( Subtotal = -$1,173 ) |
| | 2018 | 2017 | STATEGICS, INC. | 8 BAYCREST WAY | SOUTH SAN FRANCISCO | CA | 94080-7320 | SAN MATEO | USA | R43TR001596 | Development of a Homogeneous Screening Assay for the Tissue-Protective EPOR | 000 | 1 | NIH | 2/22/2018 | $0 |
| | 2018 | 2017 | STATEGICS, INC. | 8 BAYCREST WAY | SOUTH SAN FRANCISCO | CA | 94080-7320 | SAN MATEO | USA | R43TR001596 | Development of a Homogeneous Screening Assay for the Tissue-Protective EPOR | 001 | 1 | NIH | 8/20/2018 | -$1,173 |
|
| Issue Date FY: 2017 ( Subtotal = $242,013 ) |
| | 2017 | 2017 | STATEGICS, INC. | 8 BAYCREST WAY | SOUTH SAN FRANCISCO | CA | 94080-7320 | SAN MATEO | USA | R43TR001596 | Development of a Homogeneous Screening Assay for the Tissue-Protective EPOR | 000 | 1 | NIH | 1/17/2017 | $242,013 |
|
| Issue Date FY: 2013 ( Subtotal = $227,624 ) |
| | 2013 | 2013 | STATEGICS INC | 525 DEL REY AVENUE | SUNNYVALE | CA | 94085 | SANTA CLARA | USA | R43DK100140 | SMALL MOLECULE ERYTHROPOIETIN RECEPTOR AGONISTS FOR THE TREATMENT OF ACUTE KIDNEY | 000 | 1 | NIH | 7/31/2013 | $227,624 |
|
| Issue Date FY: 2008 ( Subtotal = $187,651 ) |
| | 2008 | 2008 | STATEGICS INC | 525 DEL REY AVENUE | SUNNYVALE | CA | 94085 | SANTA CLARA | USA | R43NS062494 | LOW MOLECULAR WEIGHT ERYTHROPOIETIN MIMETICS FOR IMPROVED CNS PENETRANCE AND TREA | 000 | 1 | NIH | 8/8/2008 | $187,651 |
|
|
